| # | Drug | Count |
|---|---|---|
| 0 | ATEZOLIZUMAB | 2 |
| 1 | BEVACIZUMAB | 2 |
| 2 | CARBOPLATIN | 2 |
| 3 | PACLITAXEL | 2 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 2 |
| 5 | RISANKIZUMAB-RZAA | 2 |
| 6 | VEDOLIZUMAB | 2 |
| 7 | ADALIMUMAB | 1 |
| 8 | CETIRIZINE HYDROCHLORIDE | 1 |
| 9 | EVOLOCUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | 1 | 0.0006 |
| 1 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 2 | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | 1 | 0.0002 |
| 3 | ATEZOLIZUMAB | 2 | 0.0001 |
| 4 | MESALAMINE | 1 | 0.0000 |
| 5 | VEDOLIZUMAB | 2 | 0.0000 |
| 6 | PACLITAXEL | 2 | 0.0000 |
| 7 | BEVACIZUMAB | 2 | 0.0000 |
| 8 | CARBOPLATIN | 2 | 0.0000 |
| 9 | FLUCONAZOLE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |
| 1 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Aminosalicylate [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 5 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 6 | Loop Diuretic [EPC] | 1 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 1 | 0.0000 |